Federal Register / Vol. 89, No. 249 / Monday, December 30, 2024 / Notices 106539 

Review Panel chartered by the HHS, and 

assists providers with Malpractice 

Claims Review Panel interactions; (14) 

submits payment reports to the National 

Practitioner Data Bank; (15) maintains 

case files and a malpractice claims 

database; (16) provides case summaries, 

peer review, outcome information, and 

feedback of risk management 

recommendations; (17) disseminates 

information about the review process; 

(18) responds to outside organizations 

requesting tort claim-involvement 

histories on former employees; and (19) 

responds to Tort Claims inquiries from 

governmental agencies, media, Tribal 

and Urban Indian organizations, and 

advocacy groups with the Office of 

General Council guidance. 

Division of Innovation and 

Improvement (GAPC) 

(1) Provides trainings on innovative 

thinking and performance improvement 

techniques; (2) provides training on 

empathy and relational intelligence to 

better understand colleagues and 

stakeholders and maximize teamwork; 

(3) integrates innovative thinking into 

quality improvement and policy 

formation processes to stimulate rapid 

idea generation; (4) oversees training 

programs to increase quality 

improvement capacity and standardize 

improvement methodology to test smallscale changes at the local level; (5) 

reviews use of health information 

technology and data to improve 

performance, quality and service; (6) 

monitors patient and staff satisfaction 

with health care service delivery; (7) 

leads change management for practice 

transformation to embrace new models 

of care delivery and to enhance 

efficiency of the care delivery process; 

(8) develops programs to promote the 

implementation of patient-centered care 

models; (9) coordinates sharing of best 

practices between Area Quality 

Managers and Service Unit Quality 

Assurance and Performance 

Improvement officers; and (10) supports 

and promotes patient-centered care 

including Patient and Family 

Engagement, and promotes unification 

of Area Quality Managers and Service 

Unit Quality Assurance and 

Performance Improvement Officers. 

Division of Compliance (GAPD) 

(1) Coordinates the IHS’s compliance 

program; (2) administers the agency’s 

internal control program in accordance 

with the Federal Managers’ Financial 

Integrity Act, OMB Circular No. A–123, 

GAO Green Book, and other applicable 

requirements; (3) oversees and 

coordinates the agency’s efforts to 

establish and maintain proper internal 

controls; (4) oversees and 

institutionalizes a continuous 

compliance review process; (5) manages 

goals and objectives for the Compliance 

program, integrates them with broader 

IHS-wide strategic goals/objectives, and 

tracks progress toward achieving them; 

(6) evaluates and monitors systems of 

internal control across IHS and uses the 

assessments of the internal control 

program as an integral part of ERM to 

effectively manage risks across IHS; (7) 

Serves as the IHS liaison office to the 

Government Accountability Office 

(GAO) and Office of Inspector General 

(OIG); (8) coordinates the development, 

clearance, and transmittal of IHS 

responses and follow-up to reports 

issued by the OIG, the GAO, and other 

federal internal and external authorities 

reviewing risk management and internal 

controls; (9) provides leadership and 

direction on activities for continuous 

improvement of management 

accountability and administrative 

systems for effective and efficient 

program support services IHS-wide; and 

(10) oversees and coordinates the 

annual development and submission of 

the agency’s federal Activities Inventory 

Reform Act report to the HHS. 

Section GA–30, Indian Health Service— 

Delegations of Authority 

All delegations of authority and redelegations of authority made to IHS 

officials that were in effect immediately 

prior to this reorganization, and that are 

consistent with this reorganization, 

shall continue in effect pending further 

re-delegation. 

Roselyn Tso, 

Director, Indian Health Service. 

[FR Doc. 2024–31273 Filed 12–27–24; 8:45 am] 

BILLING CODE 4166–14–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute on Aging; Notice of 

Closed Meeting 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute on 

Aging Special Emphasis Panel; NHP Review. 

Date: January 31, 2025. 

Time: 10:30 a.m. to 1:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Address: National Institute on Aging, 5601 

Fishers Lane, Suite 8B, Rockville, MD 20892. 

Meeting Format: Virtual Meeting. 

Contact Person: Bita Nakhai, Ph.D., 

Scientific Review Officer, National Institute 

on Aging, National Institutes of Health, 5601 

Fishers Lane, Suite 8B, Rockville, MD 20852, 

(301) 402–7701, nakhaib@nia.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.866, Aging Research, 

National Institutes of Health, HHS) 

Dated: December 19, 2024. 

Miguelina Perez, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2024–30880 Filed 12–27–24; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of General Medical 

Sciences; Notice of Closed Meeting 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

General Medical Sciences Initial Review 

Group Training and Workforce Development 

Study Section—C Training & Workforce 

Development Study Section C (TWD–C) 

Review of applications for the B2B & 

IRACDA Programs and Scientific Meetings & 

Conferences. 

Date: February 20–21, 2025. 

Time: 10:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Address: National Institutes of Health, 

National Institute of General Medical 

Sciences, Natcher Building, 45 Center Drive, 

Bethesda, Maryland 20892. 

Meeting Format: Virtual Meeting. 

Contact Person: Sonia Ivette OrtizMiranda, Ph.D., Scientific Review Officer, 


ddrumheller on DSK120RN23PROD with NOTICES1